Millennium Management LLC Has $569,000 Stock Position in Senseonics Holdings, Inc. (NYSE:SENS)

Millennium Management LLC increased its position in shares of Senseonics Holdings, Inc. (NYSE:SENS) by 299.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,088,029 shares of the company’s stock after acquiring an additional 815,332 shares during the period. Millennium Management LLC owned about 0.18% of Senseonics worth $569,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the company. Jane Street Group LLC grew its stake in Senseonics by 6,694.1% during the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock valued at $3,203,000 after acquiring an additional 6,028,726 shares in the last quarter. First Light Asset Management LLC bought a new position in Senseonics in the fourth quarter worth about $3,366,000. Northern Trust Corp increased its stake in shares of Senseonics by 11.2% in the 4th quarter. Northern Trust Corp now owns 1,194,960 shares of the company’s stock worth $625,000 after acquiring an additional 120,441 shares in the last quarter. Beck Mack & Oliver LLC purchased a new stake in Senseonics during the 4th quarter valued at $79,000. Finally, XTX Topco Ltd purchased a new stake in shares of Senseonics during the 4th quarter valued at about $179,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

Senseonics Trading Down 0.3%

Shares of SENS opened at $0.53 on Monday. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. Senseonics Holdings, Inc. has a 12-month low of $0.25 and a 12-month high of $1.40. The firm has a market capitalization of $344.71 million, a PE ratio of -4.05 and a beta of 0.96. The stock’s fifty day simple moving average is $0.60 and its 200-day simple moving average is $0.66.

Analysts Set New Price Targets

SENS has been the subject of a number of research reports. Mizuho assumed coverage on shares of Senseonics in a report on Thursday, April 10th. They issued an “outperform” rating and a $2.00 target price for the company. Wall Street Zen upgraded Senseonics to a “sell” rating in a report on Monday, May 12th. Finally, HC Wainwright set a $1.10 price target on Senseonics and gave the stock a “buy” rating in a research report on Monday, June 2nd.

Senseonics Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.